Lung Cancer Panel 1 EGFR ALK1 Test
At DNA Labs UAE, we offer the Lung Cancer Panel 1 EGFR ALK1 Test for the diagnosis of lung cancer. This test is designed to identify specific genetic alterations in the EGFR and ALK1 genes, which are commonly found in non-small cell lung cancer (NSCLC) patients.
Test Components
- Paraffin embedded tissue blocks
Price
AED 3600.0
Sample Condition
Tumor tissue
Report Delivery
5-7 days
Method
FISH, Sanger Sequencing
Test Type
Genetics
Doctor
Oncology
Test Department
Pre Test Information
Pre Test Information
The Lung Cancer Panel 1 EGFR ALK1 Test can be done with a doctor’s prescription. Please note that the prescription is not applicable for surgery and pregnancy cases or individuals planning to travel abroad.
Test Details
The Lung Cancer Panel 1 EGFR ALK1 Test includes testing for EGFR mutations and ALK gene rearrangements. Here is some information about these genetic alterations:
EGFR (Epidermal Growth Factor Receptor)
EGFR is a protein that regulates cell growth and division. Mutations in the EGFR gene can lead to increased receptor activity, resulting in uncontrolled cell growth and the development of cancer. EGFR mutations are commonly found in NSCLC and can be targeted with specific drugs known as EGFR inhibitors.
ALK1 (Anaplastic Lymphoma Kinase)
ALK1 is a gene that encodes for a protein called anaplastic lymphoma kinase. ALK gene rearrangements can occur in a subset of NSCLC patients, leading to the production of an abnormal ALK protein that promotes cell growth and division. ALK inhibitors are targeted therapies that specifically block the activity of the abnormal ALK protein, inhibiting the growth of cancer cells.
The Lung Cancer Panel 1 EGFR ALK1 Test is used to identify patients who may benefit from targeted therapies that specifically target these genetic alterations.
Test Name | Lung Cancer Panel 1 EGFR ALK1 Test |
---|---|
Components | Paraffin embedded tissue blocks |
Price | 3600.0 AED |
Sample Condition | Tumor tissue |
Report Delivery | 5-7 days |
Method | FISH,Sanger Sequencing |
Test type | Genetics |
Doctor | Oncology |
Test Department: | |
Pre Test Information | Lung Cancer Panel 1 EGFR, ALK1] can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad. |
Test Details |
EGFR (Epidermal Growth Factor Receptor): EGFR is a protein that is involved in regulating cell growth and division. Mutations in the EGFR gene can lead to increased activity of the receptor, resulting in uncontrolled cell growth and the development of cancer. EGFR mutations are commonly found in non-small cell lung cancer (NSCLC) and can be targeted with specific drugs known as EGFR inhibitors. ALK1 (Anaplastic Lymphoma Kinase): ALK1 is a gene that encodes for a protein called anaplastic lymphoma kinase. ALK gene rearrangements can occur in a subset of NSCLC patients, leading to the production of an abnormal ALK protein that promotes cell growth and division. ALK inhibitors are targeted therapies that specifically block the activity of the abnormal ALK protein, inhibiting the growth of cancer cells. The Lung Cancer Panel 1 includes testing for EGFR mutations and ALK gene rearrangements. This panel is used to identify patients who may benefit from targeted therapies that specifically target these genetic alterations. |